Ambulatory blood pressure monitoring in patients on rivaroxaban
Research type
Research Study
Full title
Ambulatory blood pressure monitoring in patients on rivaroxaban
IRAS ID
172638
Contact name
Kathryn Lang
Contact email
Sponsor organisation
King's College Hospital NHS Foundation Trust
Duration of Study in the UK
0 years, 5 months, 30 days
Research summary
In around one in ten patients started on rivaroxaban (a blood thinning drug), there are reports of dizziness and light-headedness, this has not been studied as yet. We intend to measure patients blood pressure over the course of 48 hours while they are taking rivaroxaban, patients will record symptoms and drug timings concurrently. We will attempt to find correlation between blood pressure, symptoms and drug timings to explain these clinical findings.
REC name
East Midlands - Derby Research Ethics Committee
REC reference
15/EM/0221
Date of REC Opinion
26 May 2015
REC opinion
Further Information Favourable Opinion